Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System

NCT: NCT02161874 · COMPLETED

NCT IDNCT02161874
StatusCOMPLETED
Start Date2013-04
Completion2020-07

Brief Summary

This study evaluates the T3 implant system for the preservation of alveolar crestal bone and the establishment of initial integration. The new surface-treated features of the implant may contribute to improved soft and hard tissue healing. The success rate of the T3 implant will be no different than that of the control implant, which possess similar geometry but different surface treatments.

Frequently Asked Questions

What is Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System?

Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System is a clinical trial registered under NCT02161874. Current status: COMPLETED.

What is the status of NCT02161874?

The current status of NCT02161874 (Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System) is: COMPLETED.

When did Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System start?

Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System started on 2013-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑